CJC-1295 NO DAC + IPAMORELIN — 10 MG + 10 MG

This research combination targets two complementary components of growth-hormone signaling. CJC-1295 No DAC is a short-acting GHRH analog, while ipamorelin activates the ghrelin receptor. The combination has generated research interest surrounding pulsatile GH release, IGF-1 signaling, recovery, sleep, and body composition. Contains 10 MG CJC-1295 NO DAC + 10 MG IPAMORELIN per vial (20 MG total).